These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33270351)

  • 1. Pathways to Severe COVID-19 for People with Obesity.
    O'Rourke RW; Lumeng CN
    Obesity (Silver Spring); 2021 Apr; 29(4):645-653. PubMed ID: 33270351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.
    Valerio A; Nisoli E; Rossi AP; Pellegrini M; Todesco T; El Ghoch M
    J Popul Ther Clin Pharmacol; 2020 Jun; 27(S Pt 1):e31-e36. PubMed ID: 32650354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
    Weis N; Thorsteinsson K; Martinussen C; Madsbad S
    Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Obesity: Overlapping of Two Pandemics.
    Gammone MA; D'Orazio N
    Obes Facts; 2021; 14(6):579-585. PubMed ID: 34569546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis.
    Chu Y; Yang J; Shi J; Zhang P; Wang X
    Eur J Med Res; 2020 Dec; 25(1):64. PubMed ID: 33267871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and Risk of COVID-19 Infection and Severity: Available Evidence and Mechanisms.
    Abiri B; Guest PC; Vafa M
    Adv Exp Med Biol; 2021; 1321():97-107. PubMed ID: 33656716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Obesity and COVID-19: A Detrimental Intersection.
    Gammone MA; D'Orazio N
    Front Endocrinol (Lausanne); 2021; 12():652639. PubMed ID: 33995281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess body weight is an independent risk factor for severe forms of COVID-19.
    Pietri L; Giorgi R; Bégu A; Lojou M; Koubi M; Cauchois R; Grangeot R; Dubois N; Kaplanski G; Valéro R; Béliard S
    Metabolism; 2021 Apr; 117():154703. PubMed ID: 33421506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.
    Khwatenge CN; Pate M; Miller LC; Sang Y
    Front Immunol; 2021; 12():732913. PubMed ID: 34737743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness.
    Kuperberg SJ; Navetta-Modrov B
    Am J Respir Cell Mol Biol; 2021 Jul; 65(1):13-21. PubMed ID: 33797351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and obesity: the confrontation of two pandemics.
    Oboza P; Ogarek N; Olszanecka-Glinianowicz M; Kocelak P
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):695-709. PubMed ID: 35113445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and clinical severity in patients with COVID-19: a scoping review protocol.
    Costa ML; Souza CAS; Silva ACC; Santos DFC; Nonato EF; Santana FB; Dos Santos Dias G; Barreto JT; Costa LS; Costa MCB; das Neves Ferreira T; Santana JS; Mendes-Netto RS; do Nascimento TVSB; Nunes MAP; de Souza MFC
    Syst Rev; 2021 Feb; 10(1):51. PubMed ID: 33550984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
    Frasca D; Reidy L; Cray C; Diaz A; Romero M; Kahl K; Blomberg BB
    PLoS One; 2021; 16(3):e0245424. PubMed ID: 33760825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intersection between COVID-19 and obesity in the context of an emerging country.
    Pinhel MAS; Watanabe LM; Noronha NY; Junior WS; Nonino CB
    Clin Nutr ESPEN; 2021 Aug; 44():472-474. PubMed ID: 34330509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is a potential risk factor contributing to clinical manifestations of COVID-19.
    Kang Z; Luo S; Gui Y; Zhou H; Zhang Z; Tian C; Zhou Q; Wang Q; Hu Y; Fan H; Hu D
    Int J Obes (Lond); 2020 Dec; 44(12):2479-2485. PubMed ID: 32921796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis.
    Malik P; Patel U; Patel K; Martin M; Shah C; Mehta D; Malik FA; Sharma A
    J Med Virol; 2021 Feb; 93(2):1188-1193. PubMed ID: 32975814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank.
    Patel KHK; Li X; Quint JK; Ware JS; Peters NS; Ng FS
    BMC Endocr Disord; 2021 Jul; 21(1):144. PubMed ID: 34217276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity aggravates COVID-19: A systematic review and meta-analysis.
    Yang J; Hu J; Zhu C
    J Med Virol; 2021 Jan; 93(1):257-261. PubMed ID: 32603481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Possible Mechanisms Linking Obesity to COVID-19: a Narrative Review.
    Vasheghani M; Hessami Z; Rekabi M; Abedini A; Qanavati A
    Obes Surg; 2022 May; 32(5):1689-1700. PubMed ID: 35113309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.